Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies

Abstract Perinatal brain injury can lead to significant neurological and cognitive deficits and currently no therapies can regenerate the damaged brain. Neural stem cells (NSCs) have the potential to engraft and regenerate damaged brain tissue. The aim of this systematic review was to evaluate the p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madeleine J. Smith, Madison Claire Badawy Paton, Michael C. Fahey, Graham Jenkin, Suzanne L. Miller, Megan Finch‐Edmondson, Courtney A. McDonald
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/0061f57653f24b59ac6f72966506fbc0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0061f57653f24b59ac6f72966506fbc0
record_format dspace
spelling oai:doaj.org-article:0061f57653f24b59ac6f72966506fbc02021-12-03T12:11:46ZNeural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies2157-65802157-656410.1002/sctm.21-0243https://doaj.org/article/0061f57653f24b59ac6f72966506fbc02021-12-01T00:00:00Zhttps://doi.org/10.1002/sctm.21-0243https://doaj.org/toc/2157-6564https://doaj.org/toc/2157-6580Abstract Perinatal brain injury can lead to significant neurological and cognitive deficits and currently no therapies can regenerate the damaged brain. Neural stem cells (NSCs) have the potential to engraft and regenerate damaged brain tissue. The aim of this systematic review was to evaluate the preclinical literature to determine whether NSC administration is more effective than controls in decreasing perinatal brain injury. Controlled interventional studies of NSC therapy using animal models of perinatal brain injury were identified using MEDLINE and Embase. Primary outcomes were brain infarct size, motor, and cognitive function. Data for meta‐analysis were synthesized and expressed as standardized mean difference (SMD) with 95% confidence intervals (CI), using a random effects model. We also reported secondary outcomes including NSC survival, migration, differentiation, and effect on neuroinflammation. Eighteen studies met inclusion criteria. NSC administration decreased infarct size (SMD 1.09; CI: 0.44, 1.74, P = .001; I2 = 74%) improved motor function measured via the impaired forelimb preference test (SMD 2.27; CI: 0.85, 3.69, P = .002; I2 = 86%) and the rotarod test (SMD 1.88; CI: 0.09, 3.67, P = .04; I2 = 95%). Additionally, NSCs improved cognitive function measured via the Morris water maze test (SMD of 2.41; CI: 1.16, 3.66, P = .0002; I2 = 81%). Preclinical evidence suggests that NSC therapy is promising for the treatment of perinatal brain injury. We have identified key knowledge gaps, including the lack of large animal studies and uncertainty regarding the necessity of immunosuppression for NSC transplantation in neonates. These knowledge gaps should be addressed before NSC treatment can effectively progress to clinical trial.Madeleine J. SmithMadison Claire Badawy PatonMichael C. FaheyGraham JenkinSuzanne L. MillerMegan Finch‐EdmondsonCourtney A. McDonaldWileyarticleanimal modelscell transplantationimmunosuppressionneural differentiationstem cellstissue‐specific stem cellsMedicine (General)R5-920CytologyQH573-671ENStem Cells Translational Medicine, Vol 10, Iss 12, Pp 1621-1636 (2021)
institution DOAJ
collection DOAJ
language EN
topic animal models
cell transplantation
immunosuppression
neural differentiation
stem cells
tissue‐specific stem cells
Medicine (General)
R5-920
Cytology
QH573-671
spellingShingle animal models
cell transplantation
immunosuppression
neural differentiation
stem cells
tissue‐specific stem cells
Medicine (General)
R5-920
Cytology
QH573-671
Madeleine J. Smith
Madison Claire Badawy Paton
Michael C. Fahey
Graham Jenkin
Suzanne L. Miller
Megan Finch‐Edmondson
Courtney A. McDonald
Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
description Abstract Perinatal brain injury can lead to significant neurological and cognitive deficits and currently no therapies can regenerate the damaged brain. Neural stem cells (NSCs) have the potential to engraft and regenerate damaged brain tissue. The aim of this systematic review was to evaluate the preclinical literature to determine whether NSC administration is more effective than controls in decreasing perinatal brain injury. Controlled interventional studies of NSC therapy using animal models of perinatal brain injury were identified using MEDLINE and Embase. Primary outcomes were brain infarct size, motor, and cognitive function. Data for meta‐analysis were synthesized and expressed as standardized mean difference (SMD) with 95% confidence intervals (CI), using a random effects model. We also reported secondary outcomes including NSC survival, migration, differentiation, and effect on neuroinflammation. Eighteen studies met inclusion criteria. NSC administration decreased infarct size (SMD 1.09; CI: 0.44, 1.74, P = .001; I2 = 74%) improved motor function measured via the impaired forelimb preference test (SMD 2.27; CI: 0.85, 3.69, P = .002; I2 = 86%) and the rotarod test (SMD 1.88; CI: 0.09, 3.67, P = .04; I2 = 95%). Additionally, NSCs improved cognitive function measured via the Morris water maze test (SMD of 2.41; CI: 1.16, 3.66, P = .0002; I2 = 81%). Preclinical evidence suggests that NSC therapy is promising for the treatment of perinatal brain injury. We have identified key knowledge gaps, including the lack of large animal studies and uncertainty regarding the necessity of immunosuppression for NSC transplantation in neonates. These knowledge gaps should be addressed before NSC treatment can effectively progress to clinical trial.
format article
author Madeleine J. Smith
Madison Claire Badawy Paton
Michael C. Fahey
Graham Jenkin
Suzanne L. Miller
Megan Finch‐Edmondson
Courtney A. McDonald
author_facet Madeleine J. Smith
Madison Claire Badawy Paton
Michael C. Fahey
Graham Jenkin
Suzanne L. Miller
Megan Finch‐Edmondson
Courtney A. McDonald
author_sort Madeleine J. Smith
title Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
title_short Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
title_full Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
title_fullStr Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
title_full_unstemmed Neural stem cell treatment for perinatal brain injury: A systematic review and meta‐analysis of preclinical studies
title_sort neural stem cell treatment for perinatal brain injury: a systematic review and meta‐analysis of preclinical studies
publisher Wiley
publishDate 2021
url https://doaj.org/article/0061f57653f24b59ac6f72966506fbc0
work_keys_str_mv AT madeleinejsmith neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT madisonclairebadawypaton neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT michaelcfahey neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT grahamjenkin neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT suzannelmiller neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT meganfinchedmondson neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
AT courtneyamcdonald neuralstemcelltreatmentforperinatalbraininjuryasystematicreviewandmetaanalysisofpreclinicalstudies
_version_ 1718373246573740032